July 1, 2021
July 1, 2021 – The U.S. FDA has approved an expanded indication for ArmonAirTM RespiClick® (fluticasone propionate) oral inhalation powder, manufactured by Teva. The drug, which
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Medical Insurance
June 30, 2021
June 30, 2021 – The U.S. FDA has approved RylazeTM [asparaginase erwinia chrysanthemi (recombinant)-rywn], manufactured by Jazz
June 30, 2021
June 30, 2021 – Teva Pharmaceuticals has recalled one lot of Topotecan Injection 4mg/4mL (1mg/mL) to
the retail/institutional level after receiving a complaint
June 29, 2021
June 29, 2021 – The U.S. FDA has approved Restylane® Contour, a hyaluronic acid filler manufactured
June 25, 2021
June 25, 2021 – Emergency use authorization (EUA) fact sheets for the Pfizer/BioNTech and Moderna COVID-19 vaccines now include a warning about
June 24, 2021
June 24, 2021 – The U.S. FDA has approved a new indication for Toviaz® (fesoterodine fumarate) extended-release oral tablets
June 24, 2021
June 24, 2021 – The U.S. FDA has granted emergency use authorization (EUA) to Actemra® (tocilizumab – Genentech) to treat COVID-19 in hospitalized patients who are at least
June 17, 2021
June 17, 2021 – The U.S. FDA has approved Astepro® Allergy (azelastine hydrochloride nasal spray, 0.15%), manufactured by Bayer, for over-the-counter (OTC) use to provide temporary